(lp0
S'AMPIO PHARMACEUTICALS, INC.  Files An 8-K Entry into a Material ... Market Exclusive - Mar 13, 2017 Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.'
p1
aS'Ampio Pharmaceuticals - Running On Fumes Seeking Alpha - Feb 1, 2017 My interest in Ampio Pharmaceuticals Inc.,  was established several days ago during the Optometric Leaders Forum in Montreal, Canada.'
p2
aS'Ampio Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering PR Newswire  - Aug 29, 2016 ENGLEWOOD, Colo., Aug. 29, 2016 /PRNewswire/ -- Ampio Pharmaceuticals, Inc.  today announced that it has entered into a securities purchase agreement with an institutional investor providing for the registered sale of 5,000,000&nbsp;...'
p3
aS'Looking at the Gauges on Ampio Pharmaceuticals Inc  Rives Journal - 19 hours ago Currently, the 14-day ADX for Ampio Pharmaceuticals Inc  is 21.87. Generally speaking, an ADX value from 0-25 would indicate an absent or weak trend.'
p4
aS'Ampio Pharmaceuticals Inc. AMPE  Wall Street Journal - May 20, 2011 Ampio Pharmaceuticals Inc. AMPE . search. View All companies. AT CLOSE 4:02 PM EST 03/10/17. $0.80 USD; 0.00 -0.12%.'
p5
aS'Ampio Pharmaceuticals, Inc. Announces Updates On the Regulatory Path for FDA ... PR Newswire  - Oct 14, 2015 ENGLEWOOD, Colo., Oct. 14, 2015 /PRNewswire/ - Ampio Pharmaceuticals, Inc.  today announced that Ampio met with the Division of the Transplant and Ophthalmology Products of the FDA to discuss the results of the OptimEyes&nbsp;...'
p6
aS'Ampio Pharmaceuticals Inc.  Plunges 5.48% on March 08 Equities.com - Mar 8, 2017 Ampio Pharmaceuticals Inc.  had a rough trading day for Wednesday March 08 as shares tumbled 5.48%, or a loss of $-0.0452 per share, to close at $0.78.Would You Buy Ampio Pharmaceuticals, Inc.  On These Analyst Ratings? - Fiscal StandardOne Stock Analysts Are Watching  Ampio Pharmaceuticals, Inc.  - UK Market News'
p7
aS'Ampio Pharmaceuticals  Stock Tanks Today after Treatment Fails To Reach ... TheStreet.com - Apr 20, 2015 NEW YORK  -- Ampio Pharmaceuticals  shares are down 65.76% to $2.71 in trading on Monday after the biopharmaceutical company announced that the multiple injection STRIDE study for pain reliever Ampion did not reach its primary&nbsp;...AMPIO Announces Ampion STRIDE Study Results - PR Newswire '
p8
aS'Analyst Research Consensus on Limoneira Company  Ampio ... Rives Journal - Mar 14, 2017 Sell-side analysts are offering a consensus Buy rating on shares of Limoneira Company . Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have an average recommendation of 1.30.'
p9
aS'Ampio Pharmaceuticals Inc.  Soars 5.45% on February 27 Equities.com - Feb 27, 2017 Ampio Pharmaceuticals Inc.  had a good day on the market for Monday February 27 as shares jumped 5.45% to close at $0.84.Stock Movements Activity: Ampio Pharmaceuticals, Inc.  - Is storiesAmpio Pharma  Receives Guidance from the FDA on Ampion - StreetInsider.com'
p10
a.